ATG34 Antibody

What is ATG34 and what is its role in cellular processes?

ATG34 is a paralog of ATG19 that functions as a selective autophagy receptor protein involved in the transport of α-mannosidase (Ams1) through autophagic pathways. It contains a C-terminal Ams1-binding domain (ABD) that specifically recognizes and binds to Ams1, facilitating its transport to the vacuole during nutrient starvation conditions. The protein plays a crucial role in selective autophagy, a process that was previously thought to be non-selective . Unlike general autophagy, selective autophagy involves the specific recognition and degradation of certain cellular components, and ATG34 serves as one of the receptor proteins that enable this selectivity.

How does the structure of ATG34 relate to its function?

ATG34 contains a distinct C-terminal domain (residues 246-358) that forms an Ams1-binding domain (ABD). Structural analysis using NMR spectroscopy reveals that the ABD comprises eight β-strands (A-H) arranged in an immunoglobulin-like β-sandwich fold, with two antiparallel β-sheets facing each other. This structure is remarkably similar to the ABD of ATG19, with a root mean square difference of 2.1 Å for 102 residues. The recognition of Ams1 by ATG34 occurs through specific loops in this immunoglobulin-like fold, particularly the DE loop which contains highly conserved residues (His-296 and Glu-297) that are essential for Ams1 binding . This structural arrangement allows ATG34 to function as a selective receptor in autophagy processes.

How does ATG34 differ from ATG19?

While ATG34 and ATG19 are paralogs with similar functions in selective autophagy, they exhibit some distinct characteristics:

• Sequence similarity: Both proteins share conserved regions, particularly in the loops located at the top of their immunoglobulin fold which are involved in Ams1 recognition.

• Structural differences: The ABDs of ATG34 and ATG19 show relatively large structural differences in the loops located at the bottom of the immunoglobulin fold, while maintaining similar conformations in the top loops.

• Conserved binding mechanism: Both proteins utilize the DE loop for Ams1 recognition, with conserved histidine and glutamic acid residues (His-296/Glu-297 in ATG34; His-310/Glu-311 in ATG19) being essential for this interaction .

• Expression conditions: While both proteins participate in selective autophagy, their expression and activity may be regulated differently depending on cellular conditions.

What experimental techniques are commonly used to study ATG34?

Research on ATG34 typically employs various experimental techniques:

• Protein expression and purification: Recombinant protein expression systems (typically E. coli) for producing ATG34 proteins, often as fusion proteins (e.g., with GST) for easier purification.

• Structural analysis: NMR spectroscopy for determining solution structures, requiring uniformly labeled proteins with 15N and 13C isotopes.

• Binding assays: In vitro pulldown assays to assess the interaction between ATG34 and Ams1.

• Mutational analysis: Site-directed mutagenesis to create alanine-substituted mutants for identifying critical residues involved in protein-protein interactions.

• Fluorescence microscopy: Used to visualize protein localization within cells, often utilizing GFP-fusion proteins.

• Immunoblot analysis: Western blotting to detect protein expression and processing .

What are the critical residues in ATG34 for Ams1 binding, and how can they be experimentally validated?

The DE loop of ATG34 contains critical residues for Ams1 binding, specifically His-296 and Glu-297. These residues can be experimentally validated through several methodological approaches:

Research has shown that alanine substitution of His-296 and Glu-297 in ATG34 significantly reduces Ams1 binding, establishing these residues as essential for the interaction, while mutations at Ile-300 and Lys-301 do not affect binding .

How does the binding mechanism of ATG34 compare to other antibody-antigen interactions?

The ATG34 ABD-Ams1 interaction presents an interesting parallel to certain antibody-antigen interactions:

• Similarity to camelid antibodies: Unlike conventional antibodies that use hypervariable loops from both VH and VL regions, ATG34's binding mechanism is more similar to camelid antibodies (which lack light chains) and function as monomers where hypervariable loops of the VH region are responsible for antigen binding.

• Comparison to monobodies: The interaction is also similar to monobodies, which are artificially designed proteins that use a fibronectin type III domain as a scaffold and interact with targets using similar loops in their monomeric immunoglobulin fold.

• Loop-mediated binding: ATG34 likely interacts with Ams1 using three loops (BC, DE, and FG) clustered at one side of its immunoglobulin fold, similar to how camelid antibody fragments and monobodies interact with their targets .

This comparison provides insights into the evolutionary convergence of protein recognition mechanisms and suggests potential applications in protein engineering and antibody development.

What methods can be used to quantitatively measure the binding affinity between ATG34 and Ams1?

To quantitatively measure the binding affinity between ATG34 and Ams1, researchers can employ several biophysical techniques:

• Surface Plasmon Resonance (SPR):

  • Immobilize either ATG34 or Ams1 on a sensor chip

  • Flow the partner protein at various concentrations

  • Measure association and dissociation rates

  • Calculate the equilibrium dissociation constant (KD)

• Isothermal Titration Calorimetry (ITC):

  • Directly measure the heat released or absorbed during binding

  • Determine binding stoichiometry, enthalpy, and KD in a single experiment

  • No protein labeling or immobilization required

• Microscale Thermophoresis (MST):

  • Label one of the proteins (typically with a fluorescent tag)

  • Measure changes in thermophoretic movement upon binding

  • Requires small sample amounts and works in solution

• Bio-Layer Interferometry (BLI):

  • Similar to SPR but measures wavelength shift instead of SPR angle

  • Can be performed in a 96-well format for higher throughput

• Fluorescence Anisotropy:

  • Label the smaller protein (likely the ABD of ATG34)

  • Measure changes in rotational diffusion upon complex formation

  • Suitable for real-time binding measurements

Each method has advantages depending on sample availability, required sensitivity, and the need for kinetic versus equilibrium parameters.

How can researchers differentiate between the functions of ATG34 and ATG19 in selective autophagy?

To differentiate between the functions of ATG34 and ATG19 in selective autophagy, researchers can implement several complementary approaches:

• Genetic knockout experiments:

  • Generate single knockouts (atg19Δ or atg34Δ) and double knockouts (atg19Δ atg34Δ)

  • Assess the transport of Ams1 and other cargo proteins to the vacuole

  • Compare phenotypes under different conditions (nutrient-rich vs. starvation)

• Complementation assays:

  • Express ATG19 or ATG34 in the double knockout strain

  • Determine which functions are rescued by each protein

  • Create chimeric proteins with domains swapped between ATG19 and ATG34

• Differential expression analysis:

  • Monitor expression levels of both proteins under various conditions

  • Use quantitative PCR and Western blotting to track transcriptional and translational regulation

  • Identify conditions where one protein might be preferentially expressed

• Cargo specificity determination:

  • Perform immunoprecipitation followed by mass spectrometry to identify binding partners

  • Compare the interactomes of ATG19 and ATG34

  • Validate specific interactions using in vitro binding assays

• Structure-function analysis:

  • Create point mutations in the non-conserved regions

  • Assess the impact on cargo recognition and transport

  • Determine if specific structural features confer unique functions

These approaches can help elucidate the potentially overlapping yet distinct roles of these paralogous proteins in selective autophagy pathways.

What are the optimal conditions for expressing and purifying recombinant ATG34 protein?

Based on established protocols, the optimal conditions for expressing and purifying recombinant ATG34 protein are:

• Expression system:

  • E. coli strain BL21(DE3) cultured in 2× YT medium (yeast extract, 10 g/liter; tryptone, 16 g/liter; sodium chloride, 5 g/liter)

  • For isotopically labeled protein (for NMR studies), use M9 minimal medium supplemented with [15N]ammonium chloride and D-[13C]glucose

• Expression construct:

  • Clone the ATG34 C-terminal domain (residues 246-358) into a pGEX-6p-1 vector

  • Express as a GST fusion protein for improved solubility and simplified purification

• Purification protocol:

  • Lyse cells by sonication in appropriate buffer

  • Perform affinity chromatography using glutathione-Sepharose 4B column

  • Cleave GST tag with PreScission protease

  • Further purify using size exclusion chromatography (Superdex 75 gel filtration column)

  • Elute with 20 mM Tris-HCl, pH 8.0, and 150 mM NaCl

• Protein quality assessment:

  • Verify purity by SDS-PAGE

  • Confirm identity by mass spectrometry

  • Assess folding using circular dichroism or NMR spectroscopy

• Storage conditions:

  • Store purified protein at -80°C in small aliquots to avoid freeze-thaw cycles

  • For NMR samples, maintain protein at 0.77 mM in 25 mM sodium phosphate, pH 7.0, 100 mM NaCl, and 2 mM DTT

Following these conditions should yield properly folded, functional ATG34 protein suitable for structural and functional studies.

How can researchers design and validate antibodies against ATG34 for research applications?

Designing and validating antibodies against ATG34 requires a systematic approach:

• Antigen design and preparation:

  • Select immunogenic regions based on predicted surface exposure and uniqueness

  • Express and purify recombinant ATG34 fragments or synthetic peptides

  • Ensure proper folding of recombinant fragments if conformational epitopes are targeted

• Antibody production methods:

  • Monoclonal antibody production: Immunize mice or rabbits and generate hybridomas

  • Polyclonal antibody production: Immunize rabbits with the antigen

  • Recombinant antibody approaches: Phage display or yeast display libraries

• Screening and selection:

  • Perform initial screening by ELISA against the immunogen

  • Secondary screening against full-length ATG34 protein

  • Counter-screening against ATG19 to ensure specificity

• Validation tests:

  • Western blot analysis using:

    • Cell lysates from wild-type and atg34Δ yeast strains

    • Lysates with overexpressed ATG34

  • Immunoprecipitation to confirm binding to native protein

  • Immunofluorescence microscopy to verify detection of the protein in its cellular context

  • Dot blot analysis with serial dilutions to assess sensitivity

• Epitope mapping:

  • Use truncated constructs or peptide arrays to identify the precise epitope

  • Perform competition assays to confirm epitope specificity

• Cross-reactivity assessment:

  • Test against ATG19 and other related proteins

  • Evaluate species cross-reactivity if the antibody is intended for use in multiple organisms

• Functional impact assessment:

  • Determine if the antibody interferes with ATG34-Ams1 binding

  • Assess whether it affects ATG34 function in cellular assays

By following these steps, researchers can develop and validate reliable antibodies for ATG34 detection in various experimental applications.

What are the best approaches for studying ATG34-dependent selective autophagy pathways in vivo?

To effectively study ATG34-dependent selective autophagy pathways in vivo, researchers should consider the following methodological approaches:

• Genetic manipulation techniques:

  • Create knockout strains (atg34Δ) using CRISPR-Cas9 or traditional homologous recombination

  • Generate fluorescent protein-tagged versions of ATG34 for live-cell imaging

  • Develop conditional expression systems to control ATG34 levels temporally

• Microscopy-based assays:

  • Monitor localization of GFP-fused Ams1 in different genetic backgrounds

  • Track formation of Cvt (cytoplasm-to-vacuole targeting) complexes using fluorescence microscopy

  • Employ total internal reflection fluorescence microscopy for high-resolution imaging of membrane dynamics

  • Use fluorescently labeled cargo proteins to track their transport to the vacuole

• Biochemical approaches:

  • Develop activity assays for Ams1 to measure its transport and processing

  • Perform immunoblot analysis to detect processing of autophagy markers

  • Isolate vacuoles to quantify the amount of transported cargo proteins

  • Use protein crosslinking to capture transient interactions in the pathway

• Induction and monitoring of selective autophagy:

  • Treat cells with rapamycin to induce autophagy

  • Subject cells to nitrogen starvation to activate general autophagy

  • Monitor the localization of ATG34 and its cargo during autophagy induction

  • Quantify the enzymatic activity of Ams1 in the vacuole as a measure of successful transport

• Advanced cellular assays:

  • Employ proximity labeling techniques (BioID, APEX) to identify proteins in close proximity to ATG34

  • Use split-GFP complementation to visualize protein-protein interactions in real-time

  • Perform pulse-chase experiments to track the kinetics of cargo transport

These approaches provide complementary information about the role of ATG34 in selective autophagy pathways and allow for a comprehensive understanding of its function in vivo .

How might understanding ATG34 structure and function contribute to therapeutic developments?

Understanding the structure and function of ATG34 could contribute to therapeutic developments in several ways:

• Target identification for modulating selective autophagy:

  • The detailed understanding of how ATG34 recognizes its cargo could help design molecules that enhance or inhibit selective autophagy

  • Since autophagy dysregulation is implicated in various diseases including neurodegenerative disorders and cancer, modulating this pathway could have therapeutic benefits

• Engineering selective autophagy receptors:

  • The immunoglobulin-like fold of the ATG34 ABD could serve as a scaffold for designing synthetic receptors

  • These engineered receptors could be designed to target specific cellular components for degradation, potentially clearing protein aggregates or damaged organelles

• Drug delivery applications:

  • Understanding the mechanism of ATG34-mediated protein transport could inspire novel approaches for intracellular drug delivery

  • The selective nature of ATG34-mediated transport could be harnessed to deliver therapeutic cargoes to specific cellular compartments

• Biomarker development:

  • Knowledge of ATG34 function could help identify biomarkers for autophagy dysfunction in various diseases

  • Monitoring ATG34-dependent pathways might provide insights into disease progression and response to treatments

• Antibody development strategies:

  • The structural similarity between ATG34 ABD and camelid antibodies suggests potential applications in developing single-domain antibodies for therapeutic use

  • The binding mode of ATG34 could inform the design of antibody-like molecules with enhanced specificity

The fundamental understanding of ATG34 structure and function thus opens multiple avenues for translational research and therapeutic development.

What are the current technical challenges in studying ATG34 and how might they be overcome?

Researchers face several technical challenges when studying ATG34, along with potential solutions:

• Protein solubility and stability:

  • Challenge: Native ATG34 may have solubility issues when expressed recombinantly

  • Solutions:

    • Use fusion partners (GST, MBP) to enhance solubility

    • Optimize buffer conditions with stabilizing agents

    • Express domain fragments rather than full-length protein

• Distinguishing from ATG19 functions:

  • Challenge: Functional redundancy between ATG34 and ATG19 complicates phenotypic analysis

  • Solutions:

    • Use double knockout systems followed by selective complementation

    • Develop highly specific antibodies that don't cross-react

    • Employ domain-swapping experiments to identify unique functions

• Transient protein interactions:

  • Challenge: Capturing short-lived interactions in the autophagy pathway

  • Solutions:

    • Utilize chemical crosslinking approaches

    • Employ proximity labeling techniques (BioID, APEX)

    • Develop real-time imaging approaches with high temporal resolution

• Structural analysis challenges:

  • Challenge: Obtaining high-resolution structures of ATG34 in complex with its binding partners

  • Solutions:

    • Use cryo-EM for larger complexes

    • Employ NMR for studying dynamic interactions

    • Develop stabilized complexes for crystallization

• Physiological relevance of in vitro findings:

  • Challenge: Translating in vitro binding studies to cellular functions

  • Solutions:

    • Develop cellular assays that directly measure cargo transport

    • Utilize genome-edited cell lines expressing modified versions of ATG34

    • Employ quantitative proteomics to measure global effects of ATG34 perturbation

By addressing these technical challenges with innovative approaches, researchers can advance our understanding of ATG34 biology and its role in selective autophagy pathways.

How does ATG34 research contribute to our broader understanding of selective autophagy mechanisms?

Research on ATG34 significantly enhances our understanding of selective autophagy mechanisms in several important ways:

• Challenging the non-selective autophagy paradigm:

  • ATG34 research has contributed to shifting the paradigm from viewing autophagy as a non-selective process to recognizing the importance of selective cargo recognition and transport

  • Proteomics analyses have identified proteins that are selectively degraded by autophagy, suggesting the existence of specific receptor systems

• Elucidating cargo recognition mechanisms:

  • The structural analysis of ATG34 ABD provides insights into how selective autophagy receptors recognize their cargo with high specificity

  • The immunoglobulin-like fold of ABD reveals a structural basis for protein-protein interactions in autophagy pathways

  • The identification of critical residues in the DE loop demonstrates the importance of specific molecular interactions in cargo selection

• Understanding receptor redundancy and specialization:

  • The existence of paralogs ATG19 and ATG34 with overlapping yet distinct functions illustrates how selective autophagy systems have evolved redundancy for robustness

  • The specific conditions under which each receptor functions helps explain how cells maintain homeostasis under various environmental stresses

• Revealing evolutionary relationships:

  • The structural similarity between ATG34 ABD and antibody domains suggests potential evolutionary convergence in protein recognition mechanisms

  • This parallel offers insights into how protein-protein interaction domains evolve to fulfill specific cellular functions

• Framework for identifying new selective autophagy receptors:

  • The characterization of ATG34 provides a framework for identifying other autophagy-specific receptor proteins that might be responsible for recognizing different cargoes

  • Similar structural motifs might be present in other uncharacterized proteins involved in selective autophagy

This research collectively advances our fundamental understanding of how cells achieve specificity in degradative pathways, which is essential for maintaining cellular homeostasis and responding to stress conditions.

What recent methodological advances have improved our ability to study ATG34 and related proteins?

Recent methodological advances have significantly enhanced our ability to study ATG34 and related proteins:

• Structural biology technologies:

  • Advanced NMR techniques for determining solution structures of protein domains

  • Cryo-electron microscopy for visualizing larger protein complexes at near-atomic resolution

  • Integrative structural biology approaches combining multiple experimental techniques

• Genome editing technologies:

  • CRISPR-Cas9 systems for precise genetic manipulation in various model organisms

  • Base editing and prime editing for introducing specific mutations without double-strand breaks

  • Conditionally degradable protein systems for temporal control of protein levels

• Advanced microscopy techniques:

  • Super-resolution microscopy bypassing the diffraction limit to visualize subcellular structures

  • Total internal reflection fluorescence microscopy for high-resolution imaging of membrane dynamics

  • Light-sheet microscopy for long-term imaging with reduced phototoxicity

  • Correlative light and electron microscopy for connecting protein localization with ultrastructure

• Protein-protein interaction detection:

  • Proximity labeling methods (BioID, TurboID, APEX) for identifying transient protein interactions

  • Split fluorescent protein complementation for visualizing interactions in living cells

  • Förster resonance energy transfer (FRET) for measuring protein-protein interactions in real-time

• Quantitative proteomics:

  • Stable isotope labeling with amino acids in cell culture (SILAC)

  • Tandem mass tag (TMT) labeling for multiplexed quantitative proteomics

  • Data-independent acquisition mass spectrometry for comprehensive protein quantification

• Single-cell technologies:

  • Single-cell RNA sequencing to measure cell-to-cell variability in gene expression

  • Spatial transcriptomics to correlate gene expression with subcellular localization

  • Single-cell proteomics to measure protein abundance in individual cells

These methodological advances provide researchers with powerful tools to investigate ATG34 function at multiple levels, from atomic structure to cellular dynamics, enabling a more comprehensive understanding of its role in selective autophagy .

What are the most promising directions for future ATG34 research?

Based on current knowledge and technical capabilities, several promising directions for future ATG34 research emerge:

• Comprehensive interactome mapping:

  • Systematic identification of all proteins that interact with ATG34

  • Characterization of interaction dynamics under different cellular conditions

  • Comparison with the ATG19 interactome to identify unique and shared binding partners

• Detailed structural studies of cargo recognition:

  • High-resolution structures of ATG34 in complex with Ams1

  • Molecular dynamics simulations to understand binding energetics

  • Structure-guided mutagenesis to fine-tune cargo specificity

• Regulatory mechanisms of ATG34 expression and function:

  • Identification of transcriptional and post-translational regulators

  • Investigation of how cellular stress modulates ATG34 activity

  • Understanding the spatiotemporal regulation of ATG34-dependent transport

• Development of ATG34-based research tools:

  • Engineering ATG34 variants as selective autophagy modulators

  • Creating biosensors to monitor selective autophagy in real-time

  • Developing ATG34-based systems for targeted protein degradation

• Translational research applications:

  • Exploring the potential role of selective autophagy in disease contexts

  • Investigating ATG34-like mechanisms in higher organisms

  • Developing therapeutic strategies based on selective autophagy modulation

• Evolutionary analysis of selective autophagy receptors:

  • Comparative genomics of ATG34 across fungal species

  • Identification of functional analogs in higher eukaryotes

  • Understanding how selective autophagy receptor systems evolved

These research directions will not only advance our understanding of ATG34 biology but also contribute to broader knowledge about selective autophagy mechanisms and their implications for cellular homeostasis and disease .

How might the study of ATG34 inform our understanding of disease mechanisms?

The study of ATG34 and selective autophagy mechanisms has significant implications for understanding disease mechanisms:

• Neurodegenerative disorders:

  • Selective autophagy is crucial for clearing protein aggregates in neurodegenerative diseases

  • Understanding the molecular basis of cargo selection through ATG34-like mechanisms could provide insights into why certain aggregates persist

  • This knowledge could inform strategies to enhance selective clearance of disease-associated proteins such as tau, α-synuclein, or huntingtin

• Cancer biology:

  • Autophagy plays context-dependent roles in cancer development and progression

  • Selective autophagy systems may be dysregulated in cancer cells, contributing to altered cellular homeostasis

  • The principles of cargo recognition learned from ATG34 could help explain how cancer cells adapt their degradative pathways

• Infectious diseases:

  • Selective autophagy contributes to immune defense by targeting intracellular pathogens

  • Understanding the structural basis of cargo recognition through ATG34-like mechanisms may explain how host cells recognize and target pathogens

  • This knowledge could inform strategies to enhance pathogen clearance or prevent pathogen evasion of autophagy

• Metabolic disorders:

  • Selective autophagy regulates metabolism by controlling the turnover of metabolic enzymes and organelles

  • Dysregulation of this process may contribute to metabolic diseases

  • The principles of substrate selection learned from ATG34 research might help understand how metabolic homeostasis is maintained

• Aging-related pathologies:

  • Declining autophagy efficiency is associated with aging

  • Understanding the molecular details of selective cargo recognition may explain age-related changes in protein quality control

  • This could lead to interventions that maintain efficient selective autophagy during aging

While ATG34 itself is a yeast protein, the fundamental mechanisms of selective autophagy are conserved across eukaryotes. The detailed molecular understanding gained from ATG34 research therefore provides valuable insights into how similar systems might function or malfunction in human disease contexts .

What interdisciplinary approaches could enhance our understanding of ATG34 function?

Advancing our understanding of ATG34 function would benefit greatly from interdisciplinary approaches that integrate diverse scientific disciplines:

• Computational biology and bioinformatics:

  • Molecular dynamics simulations to understand protein dynamics and interactions

  • Machine learning approaches to predict cargo specificity determinants

  • Systems biology modeling of selective autophagy networks

  • Evolutionary analysis to identify functional homologs across species

• Chemical biology:

  • Development of small molecule modulators of ATG34-cargo interactions

  • Chemical proteomics to identify binding partners and regulatory factors

  • Photocrosslinking approaches to capture transient interactions

  • Chemogenetic tools for temporal control of ATG34 function

• Synthetic biology:

  • Engineering synthetic selective autophagy receptors based on the ATG34 scaffold

  • Creating orthogonal selective autophagy systems for research applications

  • Developing cellular circuits that respond to protein aggregation by inducing selective autophagy

• Physics and engineering:

  • Advanced microscopy techniques to visualize selective autophagy in real-time

  • Microfluidic systems to study autophagy under controlled environmental conditions

  • Single-molecule force spectroscopy to measure binding kinetics and forces

• Clinical research:

  • Translating basic findings into biomarkers for autophagy dysfunction

  • Identifying potential therapeutic targets based on selective autophagy mechanisms

  • Developing diagnostic tools to assess selective autophagy efficiency in patient samples

• Artificial intelligence and data science:

  • Integration of multi-omics data to understand system-level effects of ATG34 perturbation

  • Image analysis algorithms to quantify selective autophagy in high-content screening

  • Literature mining to connect ATG34 research with broader autophagy knowledge

By combining these interdisciplinary approaches, researchers can develop a more comprehensive understanding of ATG34 function and its implications for cellular homeostasis, potentially leading to novel therapeutic strategies for diseases involving autophagy dysregulation .